Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS and SHAPE for Uterine Fibroids Pre and Post-UAE
NCT06705075Phase 2Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Jan 2025
- Primary completion
- Aug 2026
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of MRX-801, sponsored by Thomas Jefferson University. Started Jan 2025; status: recruiting.
02
Drugs
MRX-801
Beyond the preview
Go deeper on NCT06705075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06705075.